Search

LRF Immunotherapy Resources

 

An essential hallmark of the Lymphoma Research Foundation is its ability to provide the lymphoma community with the latest information on lymphoma research and treatment through its highly-regarded patient education resources. The Foundation is proud to provide education resources covering a breakthrough in cancer treatment—immunotherapy. LRF’s immunotherapy resources introduce members of the lymphoma community to this new treatment option and explains how it can harness and enhance the innate powers of the immune system to fight cancer cells.

 

View/Download Resources

To develop the best materials and programs to educate and support lymphoma patients, caregivers and advocates on the topic of immunotherapy, we invite you to complete the surveys listed below each resource.

Fact Sheet

Immunotherapy and Lymphoma

Teleconference

Advances in Immunotherapy in the Treatment of Lymphoma
Bruce D. Cheson, MD, FACP, FAAAS
Georgetown University Hospital / Lombardi Comprehensive Cancer Center

Stephen J. Schuster, MD
Hospital of the University of Pennsylvania

Video

Immunotherapy in Lymphoma
Bruce D. Cheson, MD, FACP, FAAAS
To receive your input, we kindly request you take the following steps:
  1. Complete the pre-video survey
  2. View the video
  3. Complete the post-video survey

 

Have Questions? Contact the LRF Helpline.

Trained staff members are available to answer your questions and provide individual support to you and your loved ones. Support services include:

  • Information on diagnosis, types of lymphomas, treatment options, potential side effects, and up-to-date research findings
  • Referrals to financial assistance programs, legal and insurance help
  • Clinical trial searches based on the patient's diagnosis and treatment history

Contact our Helpline, available Monday through Friday from 8:00am - 5:00pm Pacific Standard Time (PST). Call (800) 500-9976 or by email at helpline@lymphoma.org.


Program Supporters
This program is supported through unrestricted educational grants to the Lymphoma Research Foundation from: